top of page

Synterex Blog
Featured Blogs
Search


10 Most Common Risks to Your BLA or NDA Submission (and How to Mitigate Them)
When pursuing a Biologics License Application (BLA) or New Drug Application (NDA), meeting timelines is crucial. However, the path to approval is often fraught with potential delays. Understanding these risks—and knowing how to mitigate them—can make or break your timeline. Top 10 most common risks and expert tips on how to manage them effectively

Jeanette Towles
Aug 25, 2024
A Day in the Life of a Medical Writer
Step into the dynamic world of medical writing at Synterex and discover a day in the life of our talented medical writer, Cheryl Kolus.
Alex Olinger
Aug 22, 2024
Writing Regulatory Submissions with the Label in Mind: Key Strategies for Success
When preparing regulatory submissions, especially in fields like oncology, it's crucial to focus on the end goal—the drug's label or Summary of Product Characteristics (SmPC). These documents aren’t just regulatory requirements; they serve as the foundation for how the drug will be positioned in the market.

Synterex
Aug 19, 2024
Taylor Friend: Employee Spotlight
Today’s Employee Spotlight is on Taylor Friend, one of our amazing medical writers. Read our Q&A with her below.

Synterex
Aug 16, 2024
Keeping Cultural Differences in Mind as We Create Documents
As Americans, we tend to be very insular in our thinking. Since we don’t generally need to know another language, most of us don’t understand anything but English. Since we typically have far fewer vacation days than other countries, our vacations tend to be short.

Synterex
Aug 16, 2024
Aspartame: Oh, Not So Sweet
People started becoming afraid of aspartame after its labeling as “possibly carcinogenic to humans” by the World Health Organization (WHO) on July 13, 2023. Since then, there has been ongoing discussion about aspartame’s carcinogenic potential. What is aspartame?

Synterex
Aug 13, 2024
bottom of page